Changes in natural killer cells, the CD57CD8 subset, and related cytokines in healthy aging

Journal of Clinical Immunology

Volumn 18, Issue 1, 1998, Pages 31-38

  McNerlan, S E ^a   Rea, I M ^a   Alexander, H D ^b   Morris, T C M ^b  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b BELFAST CITY HOSPITAL   (United Kingdom)

Author keywords

Aging; Lymphocyte subsets; Natural killer cells; Soluble interleukin 2 receptors

Indexed keywords

CD16 ANTIGEN; CD3 ANTIGEN; CD56 ANTIGEN; CD57 ANTIGEN; CD8 ANTIGEN; CYTOKINE; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; T LYMPHOCYTE ANTIGEN;

ADULT; AGED; AGING; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNOPHENOTYPING; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; MALE; NATURAL KILLER CELL; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0031912158     PISSN: 02719142     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1023283719877     Document Type: Article

References (39)

1. Makinodan T, Kay MMB: Age influence on the immune system. Adv Immunol 29:287-330, 1980
2. Gardner ID: The effect of ageing on susceptibility to infection. Rev Infect Dis 2:801-810, 1980
3. Newell GR, Boutwell WB, Morris DL: Epidemiology of cancer. In Cancer: Principles and Practice of Oncology, VTJ De Vita, S Hellman, SA Rosenberg (eds). Philadelphia, Lippincott, 1982, pp 3-32
4. Manoussakis MN, Tzioufas AG, Silis MP, Pange PJE, Goudevenos J, Moutsopoulos HM: High prevalence of anti-cardiolipin and other autoantibodies in a healthy elderly population. Clin Exp Immunol 69:557-565, 1987
5. Sansoni P, Cossarizza A, Brianti V, Fagnoni F, Snelli G, Monti D, Marcato A, Passeri G, Ortolani C, Forti E, Fagiolo U, Passeri M, Franceschi C: Lymphocyte subsets and natural killer cell activity in healthy old people and centenarians. Blood 82:2767-2773, 1993
6. Lehtonen L, Eskola J, Vainio O, Lehtonen A: Changes in lymphocyte subsets and immune competence in very advanced age. J Gerontol 45:M108-M112, 1990
7. Nagel JE, Chrest FJ, Pyle RS, Adler WH: Monoclonal antibody analysis of T-lymphocyte subsets in young and aged adults. Immunol Commun 12:223-237, 1983
8. Rea IM, Stewart M, Campbell P, Alexander HD, Crockard AD, Morris TCM: Changes in lymphocyte subsets, interleukin 2 and soluble interleukin 2 receptor in old and very old age. Gerontology 42:69-78, 1996
9. Paganelli R, Quinti I, Fagiolo U, Cossarizza A, Ortolani C, Guerra E, Sansoni P, Pucillo LP, Scala E, Cozzi E, Bertollo L, Monti D, Franceschi C: Changes in circulating B cells and immunoglobulin classes and subclasses in a healthy aged population. Clin Exp Immunol 90:351-354, 1992
10. Abo T, Cooper MD, Balch CM: Postnatal expansion of the natural killer and killer cell population in humans identified by the monoclonal HNK-1 antibody. J Exp Med 155:321-326, 1982
11. + (CD16) large granular lymphocytes and decreased NK activity during human ageing. Clin Exp Immunol 68:340-347, 1987
12. Robertson MJ, Ritz J: Biology and clinical relevance of human natural killer cells. Blood 76:2421-2438, 1990
13. Lanier LL, Loken MR: Human lymphocyte subpopulations identified by using three colour immunoflourescence and flow cytometry analysis: Correlation of Leu-2, Leu-3, Leu-7, Leu-8 and Leu-11 cell surface antigen expression. J Immunol 132:151-156, 1984
14. + cells in normal, healthy individuals: Correlations with human cytomegalovirus (HCMV) carrier status, phenotypic and functional analyses. Clin Exp Immunol 94:297-305, 1993
15. Gratama JW, Kardol M, Naipal AMIH, Slats J, Den Ouden A, Stijnen T, D'Amaro J, The TH, Bruning JW: The influence of cytomegalovirus carrier status on lymphocyte subsets and natural immunity. Clin Exp Immunol 69:16-24, 1987
16. Lotzova E, Savary CA, Champlin RE: Genesis of human oncolytic natural killer cells from primitive CD34+CD33-bone marrow progenitors. J Immunol 150:5263-5269, 1993
17. Miller JS, Verfaille C, McGlave P: The generation of human natural killer cells from CD34+/DR-primitive progenitors in long-term hone marrow culture. Blood 80:2182-2186, 1992
18. Mrozek E, Anderson P, Caligiuri MA: Role of interleukin 15 in the development of the CD56+ NK cells from CD34+ hematopoietic progenitor cells. Blood 87:2632-2640, 1996
19. Giri JG, Ahdieh M, Eisenman J, Shanebeck K, Grabstein K, Kumaki S, Namen A, Park LS, Cosman D, Anderson D: Utilisation of the β and γ chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J 13:2822-2826, 1994
20. Gottesman SRS: Changes in T cell-mediated immunity with age: an update. Rev Biol Res Age 3:95-127, 1987
21. Rubin LA, Jay G, Nelson DL: The released interleukin 2 receptor binds interleukin 2 effectively. J Immunol 137:3841-3844, 1986
22. Treiber-Held S, Stewart DM, Barraclough HA, Kurman CC, Nelson DL: Release of sIL-2Rα from and activation of native human periperal blood mononuclear cells by recombinant IL-15. Clin Immunol Immunopathol 80:67-75, 1996
23. + T cell subsets in aging. Immunol Invest 24:891-895, 1995
24. Ligthart GJ, van Vlokhoven PC, Schult HRE, Hijmans W: The expanded null cell compartment in ageing: Increase in the number of natural killer cells and changes in T-cell and NK-cell subsets in human blood. Immunology 59:353-357, 1986
25. Abbott WC, Tayek JA, Bistrian BR, Maki T, Ainsley BM, Reid LA, Blackburn GL. The effect of nutritional support on T-lymphocyte subpopulations in protein calorie malnutrition. J Am Coll Nutr 5:577-584, 1986
26. Reu IM, Alexander HD, Crockard AD. Morris TCM: CD4 lymphopenia in very elderly people. Lancet 347:328-329, 1996
27. Pike J, Chandra RK: Effect of vitamin and trace element supplementation on immune indices in healthy elderly. Int J Vit Nutr Res 65:117-121, 1995
28. + suppressor lymphocytes in the blood of long-term surviving patients after allogeneic hone marrow transplantation. J Immunol 137:2180-2189, 1986
29. + subset. Clin Exp Immunol 62:515-524, 1985
30. + (Leu-7) and other lymphocyte subsets in long term survivors with renal allotransplants. Transplantation 39:25-29, 1985
31. James SP, Neckers LM, Graeff AS, Cossman J, Balch CM, Strober W. Suppression of immunoglobulin synthesis by lymphocyte subpopulations in patients with Crohn's disease. Gastroenterology 86:1510-1518, 1984
32. Plaeger-Marshall S, Spina CA, Giorgi JV, Mitsuyasu R, Wolfe P, Gottlieb M, Beall G: Alterations in cytotoxic and phenotypic subsets of natural killer cells in acquired immune deficiency syndrome (AIDS). J Clin Immunol 7:16-23, 1987
33. + cells in acquired immune deficiency syndrome (AIDS), AIDS-related complex and asymptomatic homosexuals. J Clin Immunol 6:502-509, 1986
34. Garcia-Sanz R, Gonzalez M, Orfao A, Moro MJ, Hernandez JM, Borrego D, Carnero M, Casanova F, Barez A, Jimenez R, Portero JA, San Miguel JF: Analysis of natural killer-associated antigens in peripheral blood and hone marrow of multiple myeloma patients and prognostic implications. Br J Haematol 93:81-88, 1996
35. Rubin LA, Nelson DL: The soluble interleukin-2 receptor: Biology, function and clinical application [Review]. Ann Intern Med 113:619-627, 1990
36. Nagler A, Lanier LL, Phillips JH: Constitutive expression of high affinity interleukin 2 receptors on human CD16-natural killer cells in vivo. J Exp Med 171:1527-1533, 1990
37. Cebrian M, Yague E, Rincon M, Lopez-Botet M, de Landazuri MO, Sanchez-Madrid F: Triggering of T cell proliferation through AIM, an activation inducer molecule expressed on activated human lymphocytes. J Exp Med 168:1621-1637, 1988
38. Lanier LL, Buck DW, Rhodes L, Ding A, Evans E, Barney C, Phillips JH: Interleukin 2 activation of natural killer cells rapidly induces the expression and phosphorylation of the Leu-23 activation antigen. J Exp Med 167:1572-1585, 1988
39. -+ ] and stimulation of protein kinase C. J Immunol 142:1854-1860, 1989